{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T13:35:53Z","timestamp":1793021753964,"version":"4.5.0"},"reference-count":241,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1038\/s41575-026-01232-6","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T12:08:10Z","timestamp":1785499690000},"page":"830-847","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Mechanisms, management and prevention of anorectal sexually transmitted infections"],"prefix":"10.1038","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5880-5731","authenticated-orcid":false,"given":"Phyu Mon","family":"Latt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9349-3080","authenticated-orcid":false,"given":"Fabian Y. S.","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9743-0829","authenticated-orcid":false,"given":"Christine M.","family":"Khosropour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5244-0070","authenticated-orcid":false,"given":"Ming J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9681-1956","authenticated-orcid":false,"given":"Shivani","family":"Pasricha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2967-3079","authenticated-orcid":false,"given":"Kevin","family":"Hybiske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1766-0657","authenticated-orcid":false,"given":"Eric P. F.","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"key":"1232_CR1","unstructured":"World Health Organization. Sexually transmitted infections (STIs). WHO https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/sexually-transmitted-infections-(stis) (2025)."},{"key":"1232_CR2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofae444","volume":"11","author":"RA Baiers","year":"2024","unstructured":"Baiers, R. A. et al. Asymptomatic rectal bacterial pathogens show large prospective relationships with HIV incidence in a cohort of young sexual and gender minorities: implications for STI screening and HIV prevention. Open Forum Infect. Dis. 11, ofae444 (2024).","journal-title":"Open Forum Infect. Dis."},{"key":"1232_CR3","doi-asserted-by":"publisher","first-page":"e396","DOI":"10.1016\/S2352-3018(19)30043-8","volume":"6","author":"EPF Chow","year":"2019","unstructured":"Chow, E. P. F., Grulich, A. E. & Fairley, C. K. Epidemiology and prevention of sexually transmitted infections in men who have sex with men at risk of HIV. Lancet HIV 6, e396\u2013e405 (2019).","journal-title":"Lancet HIV"},{"key":"1232_CR4","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s41182-025-00744-2","volume":"53","author":"M Deng","year":"2025","unstructured":"Deng, M. et al. Trends in the incidence of common sexually transmitted infections at the global, regional and national levels, 1990\u20132021: results of the Global Burden of Disease 2021 study. Trop. Med. Health 53, 70 (2025).","journal-title":"Trop. Med. Health"},{"key":"1232_CR5","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1177\/09564624251333489","volume":"36","author":"EP Davies","year":"2025","unstructured":"Davies, E. P. et al. A global meta-analysis of gonorrhoea and chlamydia prevalence among men who have sex with men from 2000 to 2022. Int. J. STD AIDS 36, 611\u2013621 (2025).","journal-title":"Int. J. STD AIDS"},{"key":"1232_CR6","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1097\/OLQ.0000000000000754","volume":"45","author":"CM Dewart","year":"2018","unstructured":"Dewart, C. M., Bernstein, K. T., DeGroote, N. P., Romaguera, R. & Turner, A. N. Prevalence of rectal chlamydial and gonococcal infections: a systematic review. Sex. Transm. Dis. 45, 287\u2013293 (2018).","journal-title":"Sex. Transm. Dis."},{"key":"1232_CR7","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.17134","volume":"2","author":"JJ Ong","year":"2019","unstructured":"Ong, J. J. et al. Global epidemiologic characteristics of sexually transmitted infections among individuals using preexposure prophylaxis for the prevention of HIV infection: a systematic review and meta-analysis. JAMA Netw. Open 2, e1917134 (2019).","journal-title":"JAMA Netw. Open"},{"key":"1232_CR8","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1136\/sextrans-2018-053950","volume":"95","author":"A Lau","year":"2019","unstructured":"Lau, A. et al. Factors associated with anorectal Chlamydia trachomatis or Neisseria gonorrhoeae test positivity in women: a systematic review and meta-analysis. Sex. Transm. Infect. 95, 361\u2013367 (2019).","journal-title":"Sex. Transm. Infect."},{"key":"1232_CR9","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1136\/sextrans-2017-053161","volume":"94","author":"NL Chandra","year":"2018","unstructured":"Chandra, N. L. et al. Detection of Chlamydia trachomatis in rectal specimens in women and its association with anal intercourse: a systematic review and meta-analysis. Sex. Transm. Infect. 94, 320\u2013326 (2018).","journal-title":"Sex. Transm. Infect."},{"key":"1232_CR10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1136\/sextrans-2020-054632","volume":"98","author":"M Tabesh","year":"2022","unstructured":"Tabesh, M. et al. Comparison of the patterns of chlamydia and gonorrhoea at the oropharynx, anorectum and urethra among men who have sex with men. Sex. Transm. Infect. 98, 11\u201316 (2022).","journal-title":"Sex. Transm. Infect."},{"key":"1232_CR11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1086\/430704","volume":"41","author":"CK Kent","year":"2005","unstructured":"Kent, C. K. et al. Prevalence of rectal, urethral, and pharyngeal chlamydia and gonorrhea detected in 2 clinical settings among men who have sex with men: San Francisco, California, 2003. Clin. Infect. Dis. 41, 67\u201374 (2005).","journal-title":"Clin. Infect. Dis."},{"key":"1232_CR12","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/5758387","volume":"2016","author":"PA Chan","year":"2016","unstructured":"Chan, P. A. et al. Extragenital infections caused by Chlamydia trachomatis and Neisseria gonorrhoeae: a review of the literature. Infect. Dis. Obstet. Gynecol. 2016, 5758387 (2016).","journal-title":"Infect. Dis. Obstet. Gynecol."},{"key":"1232_CR13","unstructured":"European Centre for Disease Prevention and Control. Lymphogranuloma venereum \u2014 Annual Epidemiological Report for 2023 (ECDC, 2023)."},{"key":"1232_CR14","doi-asserted-by":"publisher","first-page":"e1110","DOI":"10.1016\/S2214-109X(21)00221-7","volume":"9","author":"M Tsuboi","year":"2021","unstructured":"Tsuboi, M. et al. Prevalence of syphilis among men who have sex with men: a global systematic review and meta-analysis from 2000\u20132020. Lancet Glob. Health 9, e1110\u2013e1118 (2021).","journal-title":"Lancet Glob. Health"},{"key":"1232_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-29805-9","volume":"8","author":"EL Korenromp","year":"2018","unstructured":"Korenromp, E. L. et al. Syphilis prevalence trends in adult women in 132 countries \u2014 estimations using the Spectrum Sexually Transmitted Infections model. Sci. Rep. 8, 11503 (2018).","journal-title":"Sci. Rep."},{"key":"1232_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2025.1543119","volume":"13","author":"S Gedfie","year":"2025","unstructured":"Gedfie, S. et al. Prevalence and associated factors of syphilis among female sex workers in East Africa: a systematic review and meta-analysis. Front. Public Health 13, 1543119 (2025).","journal-title":"Front. Public Health"},{"key":"1232_CR17","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3390\/idr17040085","volume":"17","author":"DM Carmona Valencia","year":"2025","unstructured":"Carmona Valencia, D. M. et al. Severe rectal syphilis in the setting of profound HIV immunosuppression: a case report highlighting ERG\/CD38 immunophenotyping and a review of the literature. Infect. Dis. Rep. 17, 85 (2025).","journal-title":"Infect. Dis. Rep."},{"key":"1232_CR18","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1007\/s11606-020-06414-9","volume":"36","author":"JK Costales-Cantrell","year":"2021","unstructured":"Costales-Cantrell, J. K., Dong, E. Y., Wu, B. U. & Nomura, J. H. Syphilitic proctitis presenting as a rectal mass: a case report and review of the literature. J. Gen. Intern. Med. 36, 1098\u20131101 (2021).","journal-title":"J. Gen. Intern. Med."},{"key":"1232_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008878","volume":"16","author":"R Faris","year":"2020","unstructured":"Faris, R., McCullough, A., Andersen, S. E., Moninger, T. O. & Weber, M. M. The Chlamydia trachomatis secreted effector TmeA hijacks the N-WASP-ARP2\/3 actin remodeling axis to facilitate cellular invasion. PLoS Pathog. 16, e1008878 (2020).","journal-title":"PLoS Pathog."},{"key":"1232_CR20","doi-asserted-by":"publisher","first-page":"e02861","DOI":"10.1128\/mBio.02861-20","volume":"12","author":"G Keb","year":"2021","unstructured":"Keb, G., Ferrell, J., Scanlon, K. R., Jewett, T. J. & Fields, K. A. Chlamydia trachomatis TmeA directly activates N-WASP To promote actin polymerization and functions synergistically with tarp during invasion. mBio 12, e02861\u201320 (2021).","journal-title":"mBio"},{"key":"1232_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49350-6","volume":"15","author":"MD Romero","year":"2024","unstructured":"Romero, M. D. & Carabeo, R. A. Dynamin-dependent entry of Chlamydia trachomatis is sequentially regulated by the effectors TarP and TmeA. Nat. Commun. 15, 4926 (2024).","journal-title":"Nat. Commun."},{"key":"1232_CR22","doi-asserted-by":"publisher","DOI":"10.1128\/iai.00265-22","volume":"90","author":"RJ Suchland","year":"2022","unstructured":"Suchland, R. J. et al. Genomic analysis of MSM rectal Chlamydia trachomatis isolates identifies predicted tissue-tropic lineages generated by intraspecies lateral gene transfer-mediated evolution. Infect. Immun. 90, e0026522 (2022).","journal-title":"Infect. Immun."},{"key":"1232_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008207","volume":"15","author":"SE Howe","year":"2019","unstructured":"Howe, S. E., Shillova, N. & Konjufca, V. Dissemination of chlamydia from the reproductive tract to the gastro-intestinal tract occurs in stages and relies on chlamydia transport by host cells. PLoS Pathog. 15, e1008207 (2019).","journal-title":"PLoS Pathog."},{"key":"1232_CR24","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/s12866-016-0903-4","volume":"16","author":"N Ziklo","year":"2016","unstructured":"Ziklo, N., Huston, W. M., Taing, K., Katouli, M. & Timms, P. In vitro rescue of genital strains of Chlamydia trachomatis from interferon-\u03b3 and tryptophan depletion with indole-positive, but not indole-negative Prevotella spp. BMC Microbiol. 16, 286 (2016).","journal-title":"BMC Microbiol."},{"key":"1232_CR25","doi-asserted-by":"publisher","first-page":"3469","DOI":"10.1128\/IAI.67.7.3469-3480.1999","volume":"67","author":"JM Griffiss","year":"1999","unstructured":"Griffiss, J. M., Lammel, C. J., Wang, J., Dekker, N. P. & Brooks, G. F. Neisseria gonorrhoeae coordinately uses Pili and Opa to activate HEC-1-B cell microvilli, which causes engulfment of the gonococci. Infect. Immun. 67, 3469\u20133480 (1999).","journal-title":"Infect. Immun."},{"key":"1232_CR26","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1046\/j.1365-2958.1998.01102.x","volume":"30","author":"J Wang","year":"1998","unstructured":"Wang, J., Gray-Owen, S. D., Knorre, A., Meyer, T. F. & Dehio, C. Opa binding to cellular CD66 receptors mediates the transcellular traversal of Neisseria gonorrhoeae across polarized T84 epithelial cell monolayers. Mol. Microbiol. 30, 657\u2013671 (1998).","journal-title":"Mol. Microbiol."},{"key":"1232_CR27","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1128\/IAI.01083-10","volume":"79","author":"S Houston","year":"2011","unstructured":"Houston, S. et al. Bifunctional role of the Treponema pallidum extracellular matrix binding adhesin Tp0751. Infect. Immun. 79, 1386\u20131398 (2011).","journal-title":"Infect. Immun."},{"key":"1232_CR28","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1128\/IAI.01424-07","volume":"76","author":"MB Brinkman","year":"2008","unstructured":"Brinkman, M. B. et al. A novel Treponema pallidum antigen, TP0136, is an outer membrane protein that binds human fibronectin. Infect. Immun. 76, 1848\u20131857 (2008).","journal-title":"Infect. Immun."},{"key":"1232_CR29","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/j.2041-1014.2010.00584.x","volume":"25","author":"CV Bamford","year":"2010","unstructured":"Bamford, C. V., Francescutti, T., Cameron, C. E., Jenkinson, H. F. & Dymock, D. Characterization of a novel family of fibronectin-binding proteins with M23 peptidase domains from Treponema denticola. Mol. Oral Microbiol. 25, 369\u2013383 (2010).","journal-title":"Mol. Oral Microbiol."},{"key":"1232_CR30","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1128\/AAC.01095-09","volume":"54","author":"LV Stamm","year":"2010","unstructured":"Stamm, L. V. Global challenge of antibiotic-resistant Treponema pallidum. Antimicrob. Agents Chemother. 54, 583\u2013589 (2010).","journal-title":"Antimicrob. Agents Chemother."},{"key":"1232_CR31","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.tim.2021.03.011","volume":"29","author":"G Zhong","year":"2021","unstructured":"Zhong, G. Chlamydia overcomes multiple gastrointestinal barriers to achieve long-lasting colonization. Trends Microbiol. 29, 1004\u20131012 (2021).","journal-title":"Trends Microbiol."},{"key":"1232_CR32","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/2049-632X.12052","volume":"68","author":"L Yeruva","year":"2013","unstructured":"Yeruva, L., Spencer, N., Bowlin, A. K., Wang, Y. & Rank, R. G. Chlamydial infection of the gastrointestinal tract: a reservoir for persistent infection. Pathog. Dis. 68, 88\u201395 (2013).","journal-title":"Pathog. Dis."},{"key":"1232_CR33","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1128\/CVI.00763-12","volume":"20","author":"M Heiligenberg","year":"2013","unstructured":"Heiligenberg, M. et al. Effect of HIV and chlamydia infection on rectal inflammation and cytokine concentrations in men who have sex with men. Clin. Vaccine Immunol. 20, 1517\u20131523 (2013).","journal-title":"Clin. Vaccine Immunol."},{"key":"1232_CR34","doi-asserted-by":"publisher","first-page":"4425","DOI":"10.1128\/IAI.05659-11","volume":"79","author":"JA Ibana","year":"2011","unstructured":"Ibana, J. A. et al. Inhibition of indoleamine 2,3-dioxygenase activity by levo-1-methyl tryptophan blocks gamma interferon-induced Chlamydia trachomatis persistence in human epithelial cells. Infect. Immun. 79, 4425\u20134437 (2011).","journal-title":"Infect. Immun."},{"key":"1232_CR35","doi-asserted-by":"publisher","first-page":"12468","DOI":"10.1073\/pnas.1821652116","volume":"116","author":"SP Sherchand","year":"2019","unstructured":"Sherchand, S. P. & Aiyar, A. Ammonia generation by tryptophan synthase drives a key genetic difference between genital and ocular Chlamydia trachomatis isolates. Proc. Natl Acad. Sci. USA 116, 12468\u201312477 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1232_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0155880","volume":"11","author":"L Wang","year":"2016","unstructured":"Wang, L. et al. The chlamydia muridarum organisms fail to auto-inoculate the mouse genital tract after colonization in the gastrointestinal tract for 70 days. PLoS ONE 11, e0155880 (2016).","journal-title":"PLoS ONE"},{"key":"1232_CR37","doi-asserted-by":"publisher","first-page":"e00607","DOI":"10.1128\/JB.00607-19","volume":"202","author":"AF Voter","year":"2020","unstructured":"Voter, A. F. et al. Antigenic variation in Neisseria gonorrhoeae occurs independently of RecQ-mediated unwinding of the pilE G quadruplex. J. Bacteriol. 202, e00607\u2013e00619 (2020).","journal-title":"J. Bacteriol."},{"key":"1232_CR38","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/mi.2012.12","volume":"5","author":"Y Liu","year":"2012","unstructured":"Liu, Y., Islam, E. A., Jarvis, G. A., Gray-Owen, S. D. & Russell, M. W. Neisseria gonorrhoeae selectively suppresses the development of Th1 and Th2 cells, and enhances Th17 cell responses, through TGF-\u03b2-dependent mechanisms. Mucosal Immunol. 5, 320\u2013331 (2012).","journal-title":"Mucosal Immunol."},{"key":"1232_CR39","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/mi.2013.36","volume":"7","author":"Y Liu","year":"2014","unstructured":"Liu, Y., Liu, W. & Russell, M. W. Suppression of host adaptive immune responses by Neisseria gonorrhoeae: role of interleukin 10 and type 1 regulatory T cells. Mucosal Immunol. 7, 165\u2013176 (2014).","journal-title":"Mucosal Immunol."},{"key":"1232_CR40","doi-asserted-by":"publisher","first-page":"11218","DOI":"10.1074\/jbc.RA117.001209","volume":"293","author":"W Zhu","year":"2018","unstructured":"Zhu, W. et al. Properly folded and functional PorB from Neisseria gonorrhoeae inhibits dendritic cell stimulation of CD4+ T cell proliferation. J. Biol. Chem. 293, 11218\u201311229 (2018).","journal-title":"J. Biol. Chem."},{"key":"1232_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041260","volume":"7","author":"W Zhu","year":"2012","unstructured":"Zhu, W. et al. Neisseria gonorrhoeae suppresses dendritic cell-induced, antigen-dependent CD4 T cell proliferation. PLoS ONE 7, e41260 (2012).","journal-title":"PLoS ONE"},{"key":"1232_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0130713","volume":"10","author":"MC Ortiz","year":"2015","unstructured":"Ortiz, M. C. et al. Neisseria gonorrhoeae modulates immunity by polarizing human macrophages to a M2 profile. PLoS ONE 10, e0130713 (2015).","journal-title":"PLoS ONE"},{"key":"1232_CR43","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1128\/IAI.01973-06","volume":"75","author":"BT Leader","year":"2007","unstructured":"Leader, B. T., Godornes, C., VanVoorhis, W. C. & Lukehart, S. A. CD4+ lymphocytes and gamma interferon predominate in local immune responses in early experimental syphilis. Infect. Immun. 75, 3021\u20133026 (2007).","journal-title":"Infect. Immun."},{"key":"1232_CR44","doi-asserted-by":"publisher","first-page":"3822","DOI":"10.4049\/jimmunol.0902788","volume":"184","author":"L Giacani","year":"2010","unstructured":"Giacani, L. et al. Antigenic variation in Treponema pallidum: TprK sequence diversity accumulates in response to immune pressure during experimental syphilis. J. Immunol. 184, 3822\u20133829 (2010).","journal-title":"J. Immunol."},{"key":"1232_CR45","doi-asserted-by":"publisher","first-page":"4959","DOI":"10.1128\/IAI.02236-14","volume":"82","author":"TB Reid","year":"2014","unstructured":"Reid, T. B., Molini, B. J., Fernandez, M. C. & Lukehart, S. A. Antigenic variation of TprK facilitates development of secondary syphilis. Infect. Immun. 82, 4959\u20134967 (2014).","journal-title":"Infect. Immun."},{"key":"1232_CR46","first-page":"1","volume":"415","author":"JD Radolf","year":"2018","unstructured":"Radolf, J. D. & Kumar, S. The treponema pallidum outer membrane. Curr. Top. Microbiol. Immunol. 415, 1\u201338 (2018).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"1232_CR47","doi-asserted-by":"publisher","first-page":"S88","DOI":"10.1086\/652394","volume":"201","author":"PB Wyrick","year":"2010","unstructured":"Wyrick, P. B. Chlamydia trachomatis persistence in vitro: an overview. J. Infect. Dis. 201, S88\u2013S95 (2010).","journal-title":"J. Infect. Dis."},{"key":"1232_CR48","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.micinf.2011.03.004","volume":"13","author":"RV Schoborg","year":"2011","unstructured":"Schoborg, R. V. Chlamydia persistence-a tool to dissect chlamydia-host interactions. Microbes Infect. 13, 649\u2013662 (2011).","journal-title":"Microbes Infect."},{"key":"1232_CR49","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3389\/fcimb.2014.00071","volume":"4","author":"ME Lewis","year":"2014","unstructured":"Lewis, M. E. et al. Morphologic and molecular evaluation of Chlamydia trachomatis growth in human endocervix reveals distinct growth patterns. Front. Cell Infect. Microbiol. 4, 71 (2014).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"1232_CR50","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1136\/sextrans-2018-053825","volume":"95","author":"G van Liere","year":"2019","unstructured":"van Liere, G., Hoebe, C., Dirks, J. A., Wolffs, P. F. & Dukers-Muijrers, N. Spontaneous clearance of urogenital, anorectal and oropharyngeal Chlamydia trachomatis and Neisseria gonorrhoeae in women, MSM and heterosexual men visiting the STI clinic: a prospective cohort study. Sex. Transm. Infect. 95, 505\u2013510 (2019).","journal-title":"Sex. Transm. Infect."},{"key":"1232_CR51","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1136\/sextrans-2019-054267","volume":"96","author":"N Dukers-Muijrers","year":"2020","unstructured":"Dukers-Muijrers, N. et al. Spontaneous clearance of Chlamydia trachomatis accounting for bacterial viability in vaginally or rectally infected women (FemCure). Sex. Transm. Infect. 96, 541\u2013548 (2020).","journal-title":"Sex. Transm. Infect."},{"key":"1232_CR52","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/OLQ.0b013e3181d73639","volume":"37","author":"SK Apewokin","year":"2010","unstructured":"Apewokin, S. K., Geisler, W. M. & Bachmann, L. H. Spontaneous resolution of extragenital chlamydial and gonococcal infections prior to therapy. Sex. Transm. Dis. 37, 343\u2013344 (2010).","journal-title":"Sex. Transm. Dis."},{"key":"1232_CR53","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1136\/sextrans-2020-054500","volume":"96","author":"S Mensforth","year":"2020","unstructured":"Mensforth, S., Ayinde, O. C. & Ross, J. Spontaneous clearance of genital and extragenital Neisseria gonorrhoeae: data from GToG. Sex. Transm. Infect. 96, 556\u2013561 (2020).","journal-title":"Sex. Transm. Infect."},{"key":"1232_CR54","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1093\/cid\/ciac056","volume":"75","author":"SA Nieuwenburg","year":"2022","unstructured":"Nieuwenburg, S. A. et al. Detection of Treponema pallidum DNA during early syphilis stages in peripheral blood, oropharynx, ano-rectum and urine as a proxy for transmissibility. Clin. Infect. Dis. 75, 1054\u20131062 (2022).","journal-title":"Clin. Infect. Dis."},{"key":"1232_CR55","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.3201\/eid2910.230660","volume":"29","author":"ET Aung","year":"2023","unstructured":"Aung, E. T. et al. Treponema pallidum detection at asymptomatic oral, anal, and vaginal sites in adults reporting sexual contact with persons with syphilis. Emerg. Infect. Dis. 29, 2083\u20132092 (2023).","journal-title":"Emerg. Infect. Dis."},{"key":"1232_CR56","doi-asserted-by":"publisher","first-page":"S169","DOI":"10.1093\/cid\/ciac061","volume":"74","author":"CJ McNeil","year":"2022","unstructured":"McNeil, C. J., Kirkcaldy, R. D. & Workowski, K. Enteric infections in men who have sex with men. Clin. Infect. Dis. 74, S169\u2013S178 (2022).","journal-title":"Clin. Infect. Dis."},{"key":"1232_CR57","doi-asserted-by":"publisher","first-page":"719","DOI":"10.3201\/eid2504.181258","volume":"25","author":"TRH Read","year":"2019","unstructured":"Read, T. R. H. et al. Symptoms, sites, and significance of mycoplasma genitalium in men who have sex with men. Emerg. Infect. Dis. 25, 719\u2013727 (2019).","journal-title":"Emerg. Infect. Dis."},{"key":"1232_CR58","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1086\/380838","volume":"38","author":"JD Klausner","year":"2004","unstructured":"Klausner, J. D., Kohn, R. & Kent, C. Etiology of clinical proctitis among men who have sex with men. Clin. Infect. Dis. 38, 300\u2013302 (2004).","journal-title":"Clin. Infect. Dis."},{"key":"1232_CR59","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2807\/esm.10.05.00535-en","volume":"10","author":"L Gambotti","year":"2005","unstructured":"Gambotti, L. et al. Acute hepatitis C infection in HIV positive men who have sex with men in Paris, France, 2001-2004. Euro Surveill. 10, 115\u2013117 (2005).","journal-title":"Euro Surveill."},{"key":"1232_CR60","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2207323","volume":"387","author":"JP Thornhill","year":"2022","unstructured":"Thornhill, J. P., Antinori, A. & Orkin, C. M. Monkeypox virus infection across 16 countries \u2014 April\u2013June 2022. N. Engl. J. Med. 387, e69 (2022).","journal-title":"N. Engl. J. Med."},{"key":"1232_CR61","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1111\/jdv.17269","volume":"35","author":"HJC de Vries","year":"2021","unstructured":"de Vries, H. J. C. et al. 2021 European Guideline on the management of proctitis, proctocolitis and enteritis caused by sexually transmissible pathogens. J. Eur. Acad. Dermatol. Venereol. 35, 1434\u20131443 (2021).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"1232_CR62","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1136\/sti.78.2.90","volume":"78","author":"D Mabey","year":"2002","unstructured":"Mabey, D. & Peeling, R. W. Lymphogranuloma venereum. Sex. Transm. Infect. 78, 90\u201392 (2002).","journal-title":"Sex. Transm. Infect."},{"key":"1232_CR63","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1136\/sextrans-2021-055368","volume":"98","author":"Y Hughes","year":"2022","unstructured":"Hughes, Y. et al. Universal lymphogranuloma venereum (LGV) testing of rectal chlamydia in men who have sex with men and detection of asymptomatic LGV. Sex. Transm. Infect. 98, 582\u2013585 (2022).","journal-title":"Sex. Transm. Infect."},{"key":"1232_CR64","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1136\/sextrans-2012-050915","volume":"89","author":"NH de Vrieze","year":"2013","unstructured":"de Vrieze, N. H., van Rooijen, M., Schim van der Loeff, M. F. & de Vries, H. J. Anorectal and inguinal lymphogranuloma venereum among men who have sex with men in Amsterdam, the Netherlands: trends over time, symptomatology and concurrent infections. Sex. Transm. Infect. 89, 548\u2013552 (2013).","journal-title":"Sex. Transm. Infect."},{"key":"1232_CR65","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/OLQ.0000000000001944","volume":"51","author":"AK Gupta","year":"2024","unstructured":"Gupta, A. K. et al. The resurgence of lymphogranuloma venereum: changing presentation of lymphogranuloma venereum in the era of HIV preexposure prophylaxis, 2004 to 2022. Sex. Transm. Dis. 51, 233\u2013238 (2024).","journal-title":"Sex. Transm. Dis."},{"key":"1232_CR66","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1017\/S0950268815001168","volume":"144","author":"EP Chow","year":"2016","unstructured":"Chow, E. P. et al. Duration of syphilis symptoms at presentations in men who have sex with men in Australia: are current public health campaigns effective? Epidemiol. Infect. 144, 113\u2013122 (2016).","journal-title":"Epidemiol. Infect."},{"key":"1232_CR67","first-page":"1","volume":"65","author":"A Mindel","year":"1989","unstructured":"Mindel, A., Tovey, S. J., Timmins, D. J. & Williams, P. Primary and secondary syphilis, 20 years\u2019 experience. 2. Clinical features. Genitourin. Med. 65, 1\u20133 (1989).","journal-title":"Genitourin. Med."},{"key":"1232_CR68","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/S1473-3099(20)30838-0","volume":"21","author":"JM Towns","year":"2021","unstructured":"Towns, J. M. et al. Treponema pallidum detection in lesion and non-lesion sites in men who have sex with men with early syphilis: a prospective, cross-sectional study. Lancet Infect. Dis. 21, 1324\u20131331 (2021).","journal-title":"Lancet Infect. Dis."},{"key":"1232_CR69","first-page":"162","volume":"99,","author":"JM Towns","year":"2023","unstructured":"Towns, J. M. et al. Clinical and laboratory aspects of condylomata lata lesions of syphilis. Sex. Transm. Infect. 99, 162\u2013166 (2023).","journal-title":"Sex. Transm. Infect."},{"key":"1232_CR70","first-page":"275","volume":"36","author":"R Coelho","year":"2023","unstructured":"Coelho, R., Ribeiro, T., Abreu, N., Gon\u00e7alves, R. & Macedo, G. Infectious proctitis: what every gastroenterologist needs to know. Ann. Gastroenterol. 36, 275\u2013286 (2023).","journal-title":"Ann. Gastroenterol."},{"key":"1232_CR71","doi-asserted-by":"publisher","first-page":"865","DOI":"10.14309\/ajg.0000000000001804","volume":"117","author":"C Velez","year":"2022","unstructured":"Velez, C., Casimiro, I., Pitts, R., Streed, C. Jr. & Paul, S. Digestive health in sexual and gender minority populations. Am. J. Gastroenterol. 117, 865\u2013875 (2022).","journal-title":"Am. J. Gastroenterol."},{"key":"1232_CR72","doi-asserted-by":"publisher","first-page":"S151","DOI":"10.1097\/OLQ.0000000000001540","volume":"48","author":"EE Nash","year":"2021","unstructured":"Nash, E. E. et al. Impact of anatomic site, specimen collection timing, and patient symptom status on Neisseria gonorrhoeae culture recovery. Sex. Transm. Dis. 48, S151\u2013S156 (2021).","journal-title":"Sex. Transm. Dis."},{"key":"1232_CR73","doi-asserted-by":"publisher","first-page":"SH25242","DOI":"10.1071\/SH25242","volume":"23","author":"J Jung","year":"2026","unstructured":"Jung, J. et al. Culture yield of Neisseria gonorrhoeae: culture yield varies by anatomical site and time to culture collection. Sex. Health 23, SH25242 (2026).","journal-title":"Sex. Health"},{"key":"1232_CR74","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1001\/jama.2021.23487","volume":"327","author":"S Tuddenham","year":"2022","unstructured":"Tuddenham, S., Hamill, M. M. & Ghanem, K. G. Diagnosis and treatment of sexually transmitted infections: a review. J. Am. Med. Assoc. 327, 161\u2013172 (2022).","journal-title":"J. Am. Med. Assoc."},{"key":"1232_CR75","doi-asserted-by":"publisher","first-page":"5324","DOI":"10.1128\/JCM.43.10.5324-5326.2005","volume":"43","author":"DJ Jespersen","year":"2005","unstructured":"Jespersen, D. J., Flatten, K. S., Jones, M. F. & Smith, T. F. Prospective comparison of cell cultures and nucleic acid amplification tests for laboratory diagnosis of Chlamydia trachomatis infections. J. Clin. Microbiol. 43, 5324\u20135326 (2005).","journal-title":"J. Clin. Microbiol."},{"key":"1232_CR76","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1128\/JCM.39.5.1751-1756.2001","volume":"39","author":"E Van Dyck","year":"2001","unstructured":"Van Dyck, E., Ieven, M., Pattyn, S., Van Damme, L. & Laga, M. Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by enzyme immunoassay, culture, and three nucleic acid amplification tests. J. Clin. Microbiol. 39, 1751\u20131756 (2001).","journal-title":"J. Clin. Microbiol."},{"key":"1232_CR77","doi-asserted-by":"publisher","first-page":"e01215","DOI":"10.1128\/JCM.01215-20","volume":"58","author":"EPF Chow","year":"2020","unstructured":"Chow, E. P. F. et al. Changing from clinician-collected to self-collected throat swabs for oropharyngeal gonorrhea and chlamydia screening among men who have sex with men. J. Clin. Microbiol. 58, e01215\u2013e01220 (2020).","journal-title":"J. Clin. Microbiol."},{"key":"1232_CR78","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2024-015349","volume":"9","author":"AC Smith","year":"2024","unstructured":"Smith, A. C., Thorpe, P. G., Learner, E. R., Galloway, E. T. & Kersh, E. N. At-home specimen self-collection as an additional testing strategy for Chlamydia and gonorrhoea: a systematic literature review and meta-analysis. BMJ Glob. Health 9, e015349 (2024).","journal-title":"BMJ Glob. Health"},{"key":"1232_CR79","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1093\/ajcp\/aqae172","volume":"163","author":"ME Navas","year":"2025","unstructured":"Navas, M. E. et al. Extragenital self-collection testing for gonorrhea and Chlamydia: a feasibility study for expanding STI screening in the Veterans Health Administration. Am. J. Clin. Pathol. 163, 406\u2013410 (2025).","journal-title":"Am. J. Clin. Pathol."},{"key":"1232_CR80","unstructured":"Papp, R. J. et al. Recommendations for the Laboratory-based Detection of Chlamydia trachomatis and Neisseria gonorrhoeae \u2014 2014 (CDC, 2014)."},{"key":"1232_CR81","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1370\/afm.2942","volume":"21","author":"KJ Aaron","year":"2023","unstructured":"Aaron, K. J., Griner, S., Footman, A., Boutwell, A. & Van Der Pol, B. Vaginal swab vs urine for detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis: a meta-analysis. Ann. Fam. Med. 21, 172\u2013179 (2023).","journal-title":"Ann. Fam. Med."},{"key":"1232_CR82","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1071\/MA24033","volume":"45","author":"APS Jennison","year":"2024","unstructured":"Jennison, A. P. S. & Azzato, F. Direct sequencing technologies for bacterial sexually transmitted infections. Microbiol. Aust. 45, 112\u2013116 (2024).","journal-title":"Microbiol. Aust."},{"key":"1232_CR83","doi-asserted-by":"publisher","first-page":"321","DOI":"10.5694\/mja14.00780","volume":"202","author":"EP Chow","year":"2015","unstructured":"Chow, E. P. et al. Gonorrhoea notifications and nucleic acid amplification testing in a very low-prevalence Australian female population. Med. J. Aust. 202, 321\u2013323 (2015).","journal-title":"Med. J. Aust."},{"key":"1232_CR84","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.22890","volume":"33","author":"C Zhou","year":"2019","unstructured":"Zhou, C., Zhang, X., Zhang, W., Duan, J. & Zhao, F. PCR detection for syphilis diagnosis: status and prospects. J. Clin. Lab. Anal. 33, e22890 (2019).","journal-title":"J. Clin. Lab. Anal."},{"key":"1232_CR85","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1093\/clinchem\/hvaf072","volume":"71","author":"RS Treger","year":"2025","unstructured":"Treger, R. S., Menza, T. W., Truong, T. T. & Lieberman, J. A. Advances in syphilis diagnostics to address the 21st-century epidemic. Clin. Chem. 71, 935\u2013948 (2025).","journal-title":"Clin. Chem."},{"key":"1232_CR86","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1136\/sextrans-2016-053067","volume":"93","author":"H Kelly","year":"2017","unstructured":"Kelly, H. et al. Systematic reviews of point-of-care tests for the diagnosis of urogenital Chlamydia trachomatis infections. Sex. Transm. Infect. 93, S22\u2013S30 (2017).","journal-title":"Sex. Transm. Infect."},{"key":"1232_CR87","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1080\/14787210.2023.2280214","volume":"21","author":"W Cao","year":"2023","unstructured":"Cao, W., Thorpe, P. G., O\u2019Callaghan, K. & Kersh, E. N. Advantages and limitations of current diagnostic laboratory approaches in syphilis and congenital syphilis. Expert. Rev. Anti Infect. Ther. 21, 1339\u20131354 (2023).","journal-title":"Expert. Rev. Anti Infect. Ther."},{"key":"1232_CR88","first-page":"208","volume":"9","author":"K Whyte","year":"2024","unstructured":"Whyte, K., Chittle, A. & Tsang, R. S. Syphilis point-of-care tests (POCTs): implementation considerations in Canada. J. Assoc. Med. Microbiol. Infect. Dis. Can. 9, 208\u2013218 (2024).","journal-title":"J. Assoc. Med. Microbiol. Infect. Dis. Can."},{"key":"1232_CR89","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s42003-025-07591-1","volume":"8","author":"SJ Low","year":"2025","unstructured":"Low, S. J. et al. PathoGD: an integrative genomics approach to primer and guide RNA design for CRISPR-based diagnostics. Commun. Biol. 8, 147 (2025).","journal-title":"Commun. Biol."},{"key":"1232_CR90","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-020-4846-x","volume":"20","author":"T Huang","year":"2020","unstructured":"Huang, T. et al. MicroRNA expression profiling of peripheral blood mononuclear cells associated with syphilis. BMC Infect. Dis. 20, 165 (2020).","journal-title":"BMC Infect. Dis."},{"key":"1232_CR91","doi-asserted-by":"publisher","DOI":"10.1111\/1751-7915.70214","volume":"18","author":"Y Ahmadi","year":"2025","unstructured":"Ahmadi, Y., Yu, Y., Cui, Z., Huang, W. E. & Andersson, M. I. Clinical validation of loop-mediated isothermal amplification assays for the rapid detection of Neisseria gonorrhoeae and Chlamydia trachomatis. Microb. Biotechnol. 18, e70214 (2025).","journal-title":"Microb. Biotechnol."},{"key":"1232_CR92","doi-asserted-by":"publisher","first-page":"101289","DOI":"10.1016\/j.lanmic.2025.101289","volume":"7","author":"SJ Low","year":"2026","unstructured":"Low, S. J. et al. CRISPR-Cas-based diagnostics for point-of-care detection of sexually transmitted infections: a laboratory development and evaluation study. Lancet Microbe 7, 101289 (2026).","journal-title":"Lancet Microbe"},{"key":"1232_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00559-5","volume":"23","author":"WM Huston","year":"2023","unstructured":"Huston, W. M. Molecular-viability testing and antimicrobial resistance in sexually transmitted infections. Lancet Infect. Dis. 23, e399 (2023).","journal-title":"Lancet Infect. Dis."},{"key":"1232_CR94","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1093\/cid\/ciae401","volume":"82","author":"A Wong","year":"2026","unstructured":"Wong, A. et al. Viability of Chlamydia trachomatis in different anatomical sites \u2014 a systematic review and meta-analysis. Clin. Infect. Dis.\u00a082, 151\u2013158\u00a0(2026).","journal-title":"Clin. Infect. Dis."},{"key":"1232_CR95","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0003320","volume":"4","author":"F Cholette","year":"2024","unstructured":"Cholette, F. et al. Validity of dried blood spot testing for sexually transmitted and blood-borne infections: a narrative systematic review. PLoS Glob. Public Health 4, e0003320 (2024).","journal-title":"PLoS Glob. Public Health"},{"key":"1232_CR96","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.00311-24","volume":"62","author":"BE Hockman","year":"2024","unstructured":"Hockman, B. E. et al. Overcoming analytical and preanalytical challenges associated with extragenital home collected STI specimens. J. Clin. Microbiol. 62, e0031124 (2024).","journal-title":"J. Clin. Microbiol."},{"key":"1232_CR97","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1136\/sextrans-2019-054358","volume":"96","author":"I Toskin","year":"2020","unstructured":"Toskin, I. et al. Call to action for health systems integration of point-of-care testing to mitigate the transmission and burden of sexually transmitted infections. Sex. Transm. Infect. 96, 342\u2013347 (2020).","journal-title":"Sex. Transm. Infect."},{"key":"1232_CR98","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1097\/OLQ.0000000000000824","volume":"45","author":"A Tsoumanis","year":"2018","unstructured":"Tsoumanis, A., Hens, N. & Kenyon, C. R. Is screening for chlamydia and gonorrhea in men who have sex with men associated with reduction of the prevalence of these infections? a systematic review of observational studies. Sex. Transm. Dis. 45, 615\u2013622 (2018).","journal-title":"Sex. Transm. Dis."},{"key":"1232_CR99","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1093\/cid\/cix439","volume":"65","author":"SM Jenness","year":"2017","unstructured":"Jenness, S. M. et al. Incidence of gonorrhea and chlamydia following human immunodeficiency virus preexposure prophylaxis among men who have sex with men: a modeling study. Clin. Infect. Dis. 65, 712\u2013718 (2017).","journal-title":"Clin. Infect. Dis."},{"key":"1232_CR100","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz405","volume":"6","author":"KM Weiss","year":"2019","unstructured":"Weiss, K. M. et al. Optimizing coverage vs frequency for sexually transmitted infection screening of men who have sex with men. Open Forum Infect. Dis. 6, ofz405 (2019).","journal-title":"Open Forum Infect. Dis."},{"key":"1232_CR101","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1093\/cid\/ciz510","volume":"70","author":"N Voirin","year":"2020","unstructured":"Voirin, N. et al. Optimizing strategies for Chlamydia trachomatis and Neisseria gonorrhoeae screening in men who have sex with men: a modeling study. Clin. Infect. Dis. 70, 1966\u20131972 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"1232_CR102","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1097\/QAD.0000000000002522","volume":"34","author":"EC Tang","year":"2020","unstructured":"Tang, E. C. et al. Quarterly screening optimizes detection of sexually transmitted infections when prescribing HIV preexposure prophylaxis. AIDS 34, 1181\u20131186 (2020).","journal-title":"AIDS"},{"key":"1232_CR103","doi-asserted-by":"publisher","first-page":"e233","DOI":"10.1016\/S2352-3018(23)00299-0","volume":"11","author":"T Vanbaelen","year":"2024","unstructured":"Vanbaelen, T. et al. Effect of screening for Neisseria gonorrhoeae and Chlamydia trachomatis on incidence of these infections in men who have sex with men and transgender women taking HIV pre-exposure prophylaxis (the Gonoscreen study): results from a randomised, multicentre, controlled trial. Lancet HIV 11, e233\u2013e244 (2024).","journal-title":"Lancet HIV"},{"key":"1232_CR104","doi-asserted-by":"publisher","first-page":"e558","DOI":"10.1016\/S1473-3099(23)00356-0","volume":"23","author":"E Williams","year":"2023","unstructured":"Williams, E., Williamson, D. A. & Hocking, J. S. Frequent screening for asymptomatic Chlamydia and gonorrhoea infections in men who have sex with men: time to re-evaluate? Lancet Infect. Dis. 23, e558\u2013e566 (2023).","journal-title":"Lancet Infect. Dis."},{"key":"1232_CR105","doi-asserted-by":"publisher","DOI":"10.1177\/10872914251399618","author":"T Ludwick","year":"2025","unstructured":"Ludwick, T. et al. Are clinicians open to less asymptomatic STI screening for chlamydia and gonorrhea in gay, bisexual, and other men who have sex with men and the possibility of not treating positive diagnoses? A qualitative study from Australia. AIDS Patient Care STDS https:\/\/doi.org\/10.1177\/10872914251399618 (2025).","journal-title":"AIDS Patient Care STDS"},{"key":"1232_CR106","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1097\/OLQ.0000000000001199","volume":"47","author":"C Kenyon","year":"2020","unstructured":"Kenyon, C. Does intense sexually transmitted infection screening cause or prevent antimicrobial resistance in sexually transmitted infections? It depends on one\u2019s underlying epistemology. A viewpoint. Sex. Transm. Dis. 47, 506\u2013510 (2020).","journal-title":"Sex. Transm. Dis."},{"key":"1232_CR107","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1177\/0956462420957519","volume":"31","author":"C Kenyon","year":"2020","unstructured":"Kenyon, C., Baetselier, I. & Wouters, K. Screening for STIs in PrEP cohorts results in high levels of antimicrobial consumption. Int. J. STD AIDS 31, 1215\u20131218 (2020).","journal-title":"Int. J. STD AIDS"},{"key":"1232_CR108","first-page":"1107","volume":"221","author":"C Kenyon","year":"2020","unstructured":"Kenyon, C., Buyze, J., Spiteri, G., Cole, M. J. & Unemo, M. Population-level antimicrobial consumption is associated with decreased antimicrobial susceptibility in Neisseria gonorrhoeae in 24 European Countries: an ecological analysis. J. Infect. Dis. 221, 1107\u20131116 (2020).","journal-title":"J. Infect. Dis."},{"key":"1232_CR109","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1093\/cid\/ciy048","volume":"67","author":"C Kenyon","year":"2018","unstructured":"Kenyon, C. Risks of antimicrobial resistance in N. gonorrhoeae associated with intensive screening programs in pre-exposure prophylaxis programs. Clin. Infect. Dis. 67, 154\u2013155 (2018).","journal-title":"Clin. Infect. Dis."},{"key":"1232_CR110","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1093\/cid\/ciab680","volume":"74","author":"LA Barbee","year":"2022","unstructured":"Barbee, L. A. et al. The natural history of rectal gonococcal and chlamydial infections: the exgen study. Clin. Infect. Dis. 74, 1549\u20131556 (2022).","journal-title":"Clin. Infect. Dis."},{"key":"1232_CR111","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanmic.2025.101214","volume":"6","author":"T Vanbaelen","year":"2025","unstructured":"Vanbaelen, T., De Baetselier, I., Tsoumanis, A., Hensen, B. & Kenyon, C. Effect of decreasing the frequency of screening for Neisseria gonorrhoeae and Chlamydia trachomatis on the incidence of these infections and antimicrobial use among men who have sex with men using HIV PrEP in Belgium: a retrospective cohort study. Lancet Microbe 6, 101214 (2025).","journal-title":"Lancet Microbe"},{"key":"1232_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2024.101027","volume":"45","author":"ZW Alexiou","year":"2024","unstructured":"Alexiou, Z. W. et al. Reproductive tract complication risks following Chlamydia trachomatis infections: a long-term prospective cohort study from 2008 to 2022. Lancet Reg. Health Eur. 45, 101027 (2024).","journal-title":"Lancet Reg. Health Eur."},{"key":"1232_CR113","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1093\/cid\/cix326","volume":"65","author":"EPF Chow","year":"2017","unstructured":"Chow, E. P. F. et al. Increased syphilis testing of men who have sex with men: greater detection of asymptomatic early syphilis and relative reduction in secondary syphilis. Clin. Infect. Dis. 65, 389\u2013395 (2017).","journal-title":"Clin. Infect. Dis."},{"key":"1232_CR114","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/hiv.12020","volume":"14","author":"G Brook","year":"2013","unstructured":"Brook, G., McSorley, J. & Shaw, A. Retrospective study of the effect of enhanced systematic sexually transmitted infection screening, facilitated by the use of electronic patient records, in an HIV-infected cohort. HIV Med. 14, 347\u2013353 (2013).","journal-title":"HIV Med."},{"key":"1232_CR115","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1097\/QAI.0b013e3181e583bf","volume":"55","author":"M Bissessor","year":"2010","unstructured":"Bissessor, M., Fairley, C. K., Leslie, D., Howley, K. & Chen, M. Y. Frequent screening for syphilis as part of HIV monitoring increases the detection of early asymptomatic syphilis among HIV-positive homosexual men. J. Acquir. Immune Defic. Syndr. 55, 211\u2013216 (2010).","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"1232_CR116","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1071\/SH14164","volume":"12","author":"JA Trubiano","year":"2015","unstructured":"Trubiano, J. A. & Hoy, J. F. Taming the great: enhanced syphilis screening in HIV-positive men who have sex with men in a hospital clinic setting. Sex. Health 12, 176\u2013178 (2015).","journal-title":"Sex. Health"},{"key":"1232_CR117","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1093\/cid\/ciab582","volume":"74","author":"AN Burchell","year":"2022","unstructured":"Burchell, A. N. et al. Routinized syphilis screening among men living with human immunodeficiency virus: a stepped wedge cluster randomized controlled trial. Clin. Infect. Dis. 74, 846\u2013853 (2022).","journal-title":"Clin. Infect. Dis."},{"key":"1232_CR118","first-page":"149","volume":"99","author":"VW Jongen","year":"2023","unstructured":"Jongen, V. W. et al. Can we screen less frequently for STI among PrEP users? Assessing the effect of biannual STI screening on timing of diagnosis and transmission risk in the AMPrEP Study. Sex. Transm. Infect. 99, 149\u2013155 (2023).","journal-title":"Sex. Transm. Infect."},{"key":"1232_CR119","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1009529","volume":"17","author":"S Balakrishna","year":"2021","unstructured":"Balakrishna, S. et al. Assessing the drivers of syphilis among men who have sex with men in Switzerland reveals a key impact of screening frequency: a modelling study. PLoS Comput. Biol. 17, e1009529 (2021).","journal-title":"PLoS Comput. Biol."},{"key":"1232_CR120","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-13-606","volume":"13","author":"AR Tuite","year":"2013","unstructured":"Tuite, A. R., Fisman, D. N. & Mishra, S. Screen more or screen more often? Using mathematical models to inform syphilis control strategies. BMC Public Health 13, 606 (2013).","journal-title":"BMC Public Health"},{"key":"1232_CR121","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1097\/OLQ.0000000000001249","volume":"47","author":"AR Tuite","year":"2020","unstructured":"Tuite, A. R. et al. Exploring how epidemic context influences syphilis screening impact: a mathematical modeling study. Sex. Transm. Dis. 47, 798\u2013810 (2020).","journal-title":"Sex. Transm. Dis."},{"key":"1232_CR122","doi-asserted-by":"publisher","first-page":"S668","DOI":"10.1093\/ofid\/ofx163.1782","volume":"4","author":"K Carr","year":"2017","unstructured":"Carr, K. et al. Earlier detection of latent syphilis: every 3 month screening with MSM and HIV Open Forum Infect. Dis. 4, S668\u2013S668 (2017).","journal-title":"Open Forum Infect. Dis."},{"key":"1232_CR123","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ijid.2023.01.007","volume":"129","author":"CM Kim","year":"2023","unstructured":"Kim, C. M. et al. Determining the screening frequency for sexually transmitted infections for people who use HIV pre-exposure prophylaxis: a systematic review and meta-analysis. Int. J. Infect. Dis. 129, 181\u2013187 (2023).","journal-title":"Int. J. Infect. Dis."},{"key":"1232_CR124","volume":"40","author":"P Gupta","year":"2023","unstructured":"Gupta, P. et al. Increased syphilis testing and detection of late latent syphilis among women after switching from risk-based to opt-out testing strategy in an urban Australian sexual health clinic: a retrospective observational study. Lancet Reg. Health West. Pac. 40, 100875 (2023).","journal-title":"Lancet Reg. Health West. Pac."},{"key":"1232_CR125","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofae490","volume":"11","author":"KA Stanford","year":"2024","unstructured":"Stanford, K. A. et al. An Opt-Out emergency department screening intervention leads to major increases in diagnosis of syphilis. Open Forum Infect. Dis. 11, ofae490 (2024).","journal-title":"Open Forum Infect. Dis."},{"key":"1232_CR126","unstructured":"American College of Obstetricians and Gynecologists. Screening for syphilis in pregnancy. ACOG https:\/\/www.acog.org\/clinical\/clinical-guidance\/practice-advisory\/articles\/2024\/04\/screening-for-syphilis-in-pregnancy (2024)."},{"key":"1232_CR127","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2471\/BLT.12.107623","volume":"91","author":"GB Gomez","year":"2013","unstructured":"Gomez, G. B. et al. Untreated maternal syphilis and adverse outcomes of pregnancy: a systematic review and meta-analysis. Bull. World Health Organ. 91, 217\u2013226 (2013).","journal-title":"Bull. World Health Organ."},{"key":"1232_CR128","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0056713","volume":"8","author":"SJ Hawkes","year":"2013","unstructured":"Hawkes, S. J., Gomez, G. B. & Broutet, N. Early antenatal care: does it make a difference to outcomes of pregnancy associated with syphilis? A systematic review and meta-analysis. PLoS ONE 8, e56713 (2013).","journal-title":"PLoS ONE"},{"key":"1232_CR129","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0102203","volume":"9","author":"J Qin","year":"2014","unstructured":"Qin, J. et al. Reported estimates of adverse pregnancy outcomes among women with and without syphilis: a systematic review and meta-analysis. PLoS ONE 9, e102203 (2014).","journal-title":"PLoS ONE"},{"key":"1232_CR130","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1007\/s10096-014-2186-8","volume":"33","author":"JB Qin","year":"2014","unstructured":"Qin, J. B. et al. Synthesized prevention and control of one decade for mother-to-child transmission of syphilis and determinants associated with congenital syphilis and adverse pregnancy outcomes in Shenzhen, South China. Eur. J. Clin. Microbiol. Infect. Dis. 33, 2183\u20132198 (2014).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"1232_CR131","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1001\/jama.2022.15322","volume":"328","author":"CM Mangione","year":"2022","unstructured":"Mangione, C. M. et al. Screening for syphilis infection in nonpregnant adolescents and adults: US preventive services task force reaffirmation recommendation statement. J. Am. Med. Assoc. 328, 1243\u20131249 (2022).","journal-title":"J. Am. Med. Assoc."},{"key":"1232_CR132","unstructured":"The Royal Australian College of General Practitioners. Guidelines for Preventive Activities in General Practice 10th edn (RACGP, 2024)."},{"key":"1232_CR133","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1071\/SH22134","volume":"20","author":"JJ Ong","year":"2023","unstructured":"Ong, J. J. et al. Australian sexually transmitted infection (STI) management guidelines for use in primary care 2022 update. Sex. Health 20, 1\u20138 (2023).","journal-title":"Sex. Health"},{"key":"1232_CR134","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","volume":"70","author":"KA Workowski","year":"2021","unstructured":"Workowski, K. A. et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm. Rep. 70, 1\u2013187 (2021).","journal-title":"MMWR Recomm. Rep."},{"key":"1232_CR135","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/OLQ.0000000000000917","volume":"46","author":"MA Pitasi","year":"2019","unstructured":"Pitasi, M. A. et al. Chlamydia, gonorrhea, and human immunodeficiency virus infection among transgender women and transgender men attending clinics that provide sexually transmitted disease services in six US cities: results from the sexually transmitted disease surveillance network. Sex. Transm. Dis. 46, 112\u2013117 (2019).","journal-title":"Sex. Transm. Dis."},{"key":"1232_CR136","doi-asserted-by":"publisher","first-page":"e736","DOI":"10.1093\/cid\/ciac370","volume":"76","author":"DM Tordoff","year":"2023","unstructured":"Tordoff, D. M., Dombrowski, J. C., Ramchandani, M. S. & Barbee, L. A. Trans-inclusive sexual health questionnaire to improve human immunodeficiency virus\/sexually transmitted infection (STI) care for transgender patients: anatomic site-specific STI prevalence and screening. Clin. Infect. Dis. 76, e736\u2013e743 (2023).","journal-title":"Clin. Infect. Dis."},{"key":"1232_CR137","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1097\/OLQ.0000000000001335","volume":"48","author":"OT Van Gerwen","year":"2021","unstructured":"Van Gerwen, O. T. et al. Prevalence of and factors associated with genital and extragenital chlamydia and gonorrhea among transgender women in HIV care in the United States, 2005 to 2016. Sex. Transm. Dis. 48, 410\u2013416 (2021).","journal-title":"Sex. Transm. Dis."},{"key":"1232_CR138","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1136\/sextrans-2025-056508","volume":"102","author":"MJ Mimiaga","year":"2026","unstructured":"Mimiaga, M. J. et al. Prevalence of chlamydial, gonococcal and syphilis positivity by anatomical site and sex via self-collected biospecimens using at-home testing kits among a large and diverse cohort of men and women enrolled in the MACS\/WIHS Combined Cohort Study (MWCCS) in the USA. Sex. Transm. Infect. 102, 82\u201393 (2026).","journal-title":"Sex. Transm. Infect."},{"key":"1232_CR139","unstructured":"US Centers for Disease Control and Prevention. Guide to taking a sexual history. CDC https:\/\/www.cdc.gov\/sti\/hcp\/clinical-guidance\/taking-a-sexual-history.html (2024)."},{"key":"1232_CR140","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1097\/OLQ.0000000000001319","volume":"48","author":"KA Brookmeyer","year":"2021","unstructured":"Brookmeyer, K. A. et al. Sexual history taking in clinical settings: a narrative review. Sex. Transm. Dis. 48, 393\u2013402 (2021).","journal-title":"Sex. Transm. Dis."},{"key":"1232_CR141","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/GRF.0000000000000934","volume":"68","author":"LA Fein","year":"2025","unstructured":"Fein, L. A., Marbin, S., Barnett, R. & Coudray, M. Sexually transmitted infection considerations for transgender and gender expansive persons. Clin. Obstet. Gynecol. 68, 213\u2013222 (2025).","journal-title":"Clin. Obstet. Gynecol."},{"key":"1232_CR142","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11904-025-00736-1","volume":"22","author":"S Ma","year":"2025","unstructured":"Ma, S., Osburn, W. O. & Manabe, Y. C. Increasing access to sexually transmitted infection testing: the promise of point-of-care and over-the-counter tests. Curr. HIV\/AIDS Rep. 22, 27 (2025).","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"1232_CR143","doi-asserted-by":"publisher","first-page":"e1544","DOI":"10.1016\/S2214-109X(24)00266-3","volume":"12","author":"SL Gottlieb","year":"2024","unstructured":"Gottlieb, S. L. et al. WHO global research priorities for sexually transmitted infections. Lancet Glob. Health 12, e1544\u2013e1551 (2024).","journal-title":"Lancet Glob. Health"},{"key":"1232_CR144","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.cmi.2021.05.052","volume":"28","author":"S Vargas","year":"2022","unstructured":"Vargas, S. et al. Point-of-care testing for sexually transmitted infections in low-resource settings. Clin. Microbiol. Infect. 28, 946\u2013951 (2022).","journal-title":"Clin. Microbiol. Infect."},{"key":"1232_CR145","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s12875-024-02406-4","volume":"25","author":"M Ansu-Mensah","year":"2024","unstructured":"Ansu-Mensah, M., Bawontuo, V., Kuupiel, D. & Ginindza, T. G. Sustainable solutions to barriers of point-of-care diagnostic testing services in health facilities without laboratories in the bono region, Ghana: a qualitative study. BMC Prim. Care 25, 179 (2024).","journal-title":"BMC Prim. Care"},{"key":"1232_CR146","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1056\/NEJMoa2031631","volume":"384","author":"A Lau","year":"2021","unstructured":"Lau, A. et al. Azithromycin or doxycycline for asymptomatic rectal Chlamydia trachomatis. N. Engl. J. Med. 384, 2418\u20132427 (2021).","journal-title":"N. Engl. J. Med."},{"key":"1232_CR147","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1093\/cid\/ciab153","volume":"73","author":"JC Dombrowski","year":"2021","unstructured":"Dombrowski, J. C. et al. Doxycycline versus azithromycin for the treatment of rectal Chlamydia in men who have sex with men: a randomized controlled trial. Clin. Infect. Dis. 73,\u00a0824\u2013831\u00a0(2021).","journal-title":"Clin. Infect. Dis."},{"key":"1232_CR148","first-page":"603","volume":"17","author":"F Mohammadzadeh","year":"2019","unstructured":"Mohammadzadeh, F. et al. Urogenital Chlamydia trachomatis treatment failure with azithromycin: a meta-analysis. Int. J. Reprod. Biomed. 17, 603\u2013620 (2019).","journal-title":"Int. J. Reprod. Biomed."},{"key":"1232_CR149","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1093\/cid\/ciu220","volume":"59","author":"FYS Kong","year":"2014","unstructured":"Kong, F. Y. S. et al. Azithromycin versus doxycycline for the treatment of genital Chlamydia infection \u2014 a meta-analysis of randomised controlled trials. Clin. Infect. Dis. 59, 193\u2013205 (2014).","journal-title":"Clin. Infect. Dis."},{"key":"1232_CR150","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/S1473-3099(22)00148-7","volume":"22","author":"O Peuchant","year":"2022","unstructured":"Peuchant, O. et al. Doxycycline versus azithromycin for the treatment of anorectal Chlamydia trachomatis infection in women concurrent with vaginal infection (CHLAZIDOXY study): a multicentre, open-label, randomised, controlled, superiority trial. Lancet Infect. Dis.\u00a022,\u00a01221\u20131230\u00a0(2022).","journal-title":"Lancet Infect. Dis."},{"key":"1232_CR151","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1093\/cid\/ciz050","volume":"69","author":"N Dukers-Muijrers","year":"2019","unstructured":"Dukers-Muijrers, N. et al. Treatment effectiveness of azithromycin and doxycycline in uncomplicated rectal and vaginal Chlamydia trachomatis infections in women: a multicentre observational study (FemCure). Clin. Infect. Dis.\u00a069,\u00a01946\u20131954 (2019).","journal-title":"Clin. Infect. Dis."},{"key":"1232_CR152","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/S1473-3099(22)00173-6","volume":"22","author":"CK Fairley","year":"2022","unstructured":"Fairley, C. K., Hocking, J. S. & Kong, F. Y. S. Doxycycline: the universal treatment for anogenital Chlamydia. Lancet Infect. Dis.\u00a022,\u00a01102\u20131103\u00a0(2022).","journal-title":"Lancet Infect. Dis."},{"key":"1232_CR153","unstructured":"World Health Organization. Updated Recommendations for the Treatment of Neisseria gonorrhoeae, Chlamydia trachomatis and Treponema pallidum (Syphilis), and New Recommendations on Syphilis Testing and Partner Services (WHO, 2024)."},{"key":"1232_CR154","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1093\/jac\/dku574","volume":"70","author":"FYS Kong","year":"2015","unstructured":"Kong, F. Y. S. et al. The efficacy of azithromycin and doxycycline for the treatment of rectal chlamydia infection: a systematic review and meta-analysis. J. Antimicrob. Chemother. 70, 1290\u20131297 (2015).","journal-title":"J. Antimicrob. Chemother."},{"key":"1232_CR155","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0174372","volume":"12","author":"FYS Kong","year":"2017","unstructured":"Kong, F. Y. S. et al. Pharmacokinetics of a single 1g dose of azithromycin in rectal tissue in men. PLoS ONE 12, e0174372 (2017).","journal-title":"PLoS ONE"},{"key":"1232_CR156","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1093\/jac\/dkx392","volume":"73","author":"C Foschi","year":"2018","unstructured":"Foschi, C., Salvo, M., Cevenini, R. & Marangoni, A. Chlamydia trachomatis antimicrobial susceptibility in colorectal and endocervical cells. J. Antimicrob. Chemother. 73, 409\u2013413 (2018).","journal-title":"J. Antimicrob. Chemother."},{"key":"1232_CR157","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1017\/S0950268816000996","volume":"144","author":"F Kong","year":"2016","unstructured":"Kong, F. et al. Higher organism load associated with failure of azithromycin to treat rectal chlamydia. Epidemiol. Infect. 144, 2587\u20132596 (2016).","journal-title":"Epidemiol. Infect."},{"key":"1232_CR158","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/BF02629003","volume":"12","author":"W Bitterman","year":"1969","unstructured":"Bitterman, W., Spencer, R., Huizenga, K. & Shorter, R. Contact pH of rectal mucosa in humans and dogs. Dis. Colon Rectum 12, 96\u201398 (1969).","journal-title":"Dis. Colon Rectum"},{"key":"1232_CR159","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1071\/SH20107","volume":"18","author":"FYS Kong","year":"2021","unstructured":"Kong, F. Y. S., Woutersen, J., Kroone, M. M., Hocking, J. S. & de Vries, H. J. C. Factors associated with rectal pH among men who have sex with men. Sex. Health 18, 140\u2013146 (2021).","journal-title":"Sex. Health"},{"key":"1232_CR160","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/00007435-199905000-00006","volume":"26","author":"L Bachmann","year":"1999","unstructured":"Bachmann, L., Stephens, J., Richey, C. & Hook, E. Measured versus self-reported compliance with doxycycline therapy for chlamydia-associated syndromes \u2014 high therapeutic success rates despite poor compliance. Sex. Transm. Dis. 26, 272\u2013278 (1999).","journal-title":"Sex. Transm. Dis."},{"key":"1232_CR161","first-page":"18","volume":"5","author":"MB Reedy","year":"1997","unstructured":"Reedy, M. B. et al. Evaluation of 3-day course of doxycycline for the treatment of uncomplicated Chlamydia trachomatis cervicitis. Infect. Dis. Obstet. Gynecol. 5, 18\u201322 (1997).","journal-title":"Infect. Dis. Obstet. Gynecol."},{"key":"1232_CR162","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05840159 (2026)."},{"key":"1232_CR163","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.3201\/eid2210.160986","volume":"22","author":"C Leeyaphan","year":"2016","unstructured":"Leeyaphan, C. et al. Systematic review and meta-analysis of doxycycline efficacy for rectal lymphogranuloma venereum in men who have sex with men. Emerg. Infect. Dis. 22, 1778\u20131784 (2016).","journal-title":"Emerg. Infect. Dis."},{"key":"1232_CR164","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.1086\/597011","volume":"48","author":"HJC de Vries","year":"2009","unstructured":"de Vries, H. J. C. et al. Delayed microbial cure of lymphogranuloma venereum proctitis with doxycycline treatment. Clin. Infect. Dis. 48, e53\u2013e56 (2009).","journal-title":"Clin. Infect. Dis."},{"key":"1232_CR165","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1086\/428290","volume":"191","author":"SA Wang","year":"2005","unstructured":"Wang, S. A. et al. Evaluation of antimicrobial resistance and treatment failures for Chlamydia trachomatis: a meeting report. J. Infect. Dis. 191, 917\u2013923 (2005).","journal-title":"J. Infect. Dis."},{"key":"1232_CR166","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1093\/infdis\/162.6.1309","volume":"162","author":"RB Jones","year":"1990","unstructured":"Jones, R. B., Van Der Pol, B., Martin, D. H. & Shepard, M. K. Partial characterization of Chlamydia trachomatis isolates resistant to multiple antibiotics. J. Infect. Dis. 162, 1309\u20131315 (1990).","journal-title":"J. Infect. Dis."},{"key":"1232_CR167","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1159\/000314998","volume":"56","author":"AR Bhengraj","year":"2010","unstructured":"Bhengraj, A. R., Vardhan, H., Srivastava, P., Salhan, S. & Mittal, A. Decreased susceptibility to azithromycin and doxycycline in clinical isolates of Chlamydia trachomatis obtained from recurrently infected female patients in India. Chemotherapy 56, 371\u2013377 (2010).","journal-title":"Chemotherapy"},{"key":"1232_CR168","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1086\/315372","volume":"181","author":"J Somani","year":"2000","unstructured":"Somani, J., Bhullar, V. B., Workowski, K. A., Farshy, C. E. & Black, C. M. Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure. J. Infect. Dis. 181, 1421\u20131427 (2000).","journal-title":"J. Infect. Dis."},{"key":"1232_CR169","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/QCO.0000000000000997","volume":"37","author":"EPF Chow","year":"2024","unstructured":"Chow, E. P. F., Fairley, C. K. & Kong, F. Y. S. STI pathogens in the oropharynx: update on screening and treatment. Curr. Opin. Infect. Dis. 37, 35\u201345 (2024).","journal-title":"Curr. Opin. Infect. Dis."},{"key":"1232_CR170","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.1093\/jac\/dkab315","volume":"76","author":"F Lo","year":"2021","unstructured":"Lo, F., Kong, F. & Hocking, J. Treatment efficacy for rectal Neisseria gonorrhoeae: a systematic review and meta-analysis of randomized controlled trials. J. Antimicrob. Chemother.\u00a076,\u00a03111\u20133124\u00a0(2021).","journal-title":"J. Antimicrob. Chemother."},{"key":"1232_CR171","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/S1473-3099(21)00625-3","volume":"22","author":"HJC de Vries","year":"2022","unstructured":"de Vries, H. J. C. et al. Efficacy of ertapenem, gentamicin, fosfomycin, and ceftriaxone for the treatment of anogenital gonorrhoea (NABOGO): a randomised, non-inferiority trial. Lancet Infect. Dis. 22, 706\u2013717 (2022).","journal-title":"Lancet Infect. Dis."},{"key":"1232_CR172","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1093\/jac\/dkae063","volume":"79","author":"M Unemo","year":"2024","unstructured":"Unemo, M. et al. Pharmacodynamic evaluation of ceftriaxone single-dose therapy (0.125-1 g) to eradicate ceftriaxone-susceptible and ceftriaxone-resistant Neisseria gonorrhoeae strains in a hollow fibre infection model for gonorrhoea. J. Antimicrob. Chemother.\u00a079,\u00a01006\u20131013 (2024).","journal-title":"J. Antimicrob. Chemother."},{"key":"1232_CR173","doi-asserted-by":"publisher","first-page":"2200081","DOI":"10.2807\/1560-7917.ES.2022.27.34.2200081","volume":"27","author":"M Visser","year":"2022","unstructured":"Visser, M., Gotz, H. M., van Dam, A. P. & van Benthem, B. H. Trends and regional variations of gonococcal antimicrobial resistance in the Netherlands, 2013 to 2019. Euro Surveill. 27, 2200081 (2022).","journal-title":"Euro Surveill."},{"key":"1232_CR174","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaf320","volume":"12","author":"A Tsoumanis","year":"2025","unstructured":"Tsoumanis, A., Van Dijck, C., Hens, N. & Kenyon, C. Switching from dual to monotherapy for gonorrhea is associated with a halving of gonococcal resistance to azithromycin-A modelling study of MSM in Belgium. Open Forum Infect. Dis. 12, ofaf320 (2025).","journal-title":"Open Forum Infect. Dis."},{"key":"1232_CR175","first-page":"101663","volume":"61","author":"I Maatouk","year":"2025","unstructured":"Maatouk, I. et al. Antimicrobial resistance in Neisseria gonorrhoeae in nine sentinel countries within the World Health Organization Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP), 2023: a retrospective observational study. Lancet Reg. Health West. Pac. 61, 101663 (2025).","journal-title":"Lancet Reg. Health West. Pac."},{"key":"1232_CR176","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijregi.2025.100624","volume":"15","author":"S Jacobsson","year":"2025","unstructured":"Jacobsson, S. et al. High susceptibility to the novel antimicrobial zoliflodacin among Neisseria gonorrhoeae isolates in eight WHO Enhanced Gonococcal Antimicrobial Surveillance Programme countries in three WHO regions, 2021\u20132024. IJID Reg. 15, 100624 (2025).","journal-title":"IJID Reg."},{"key":"1232_CR177","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1056\/NEJMoa1706988","volume":"379","author":"SN Taylor","year":"2018","unstructured":"Taylor, S. N. et al. Single-dose zoliflodacin (ETX0914) for treatment of urogenital gonorrhea. N. Engl. J. Med. 379, 1835\u20131845 (2018).","journal-title":"N. Engl. J. Med."},{"key":"1232_CR178","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/S0140-6736(25)00628-2","volume":"405","author":"JDC Ross","year":"2025","unstructured":"Ross, J. D. C. et al. Oral gepotidacin for the treatment of uncomplicated urogenital gonorrhoea (EAGLE-1): a phase 3 randomised, open-label, non-inferiority, multicentre study. Lancet 405, 1608\u20131620 (2025).","journal-title":"Lancet"},{"key":"1232_CR179","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1093\/jac\/dkac118","volume":"77","author":"JJ Ong","year":"2022","unstructured":"Ong, J. J. et al. Comparison of gastrointestinal side effects from different doses of azithromycin for the treatment of gonorrhoea. J. Antimicrob. Chemother.\u00a077,\u00a02011\u20132016 (2022).","journal-title":"J. Antimicrob. Chemother."},{"key":"1232_CR180","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1093\/jac\/dky548","volume":"74","author":"FYS Kong","year":"2019","unstructured":"Kong, F. Y. S., Horner, P., Unemo, M. & Hocking, J. S. Pharmacokinetic considerations regarding the treatment of bacterial sexually transmitted infections with azithromycin: a review. J. Antimicrob. Chemother. 74, 1157\u20131166 (2019).","journal-title":"J. Antimicrob. Chemother."},{"key":"1232_CR181","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0140-6736(25)01953-1","volume":"407","author":"A Luckey","year":"2026","unstructured":"Luckey, A. et al. Zoliflodacin versus ceftriaxone plus azithromycin for treatment of uncomplicated urogenital gonorrhoea: an international, randomised, controlled, open-label, phase 3, non-inferiority clinical trial. Lancet 407, 147\u2013160 (2026).","journal-title":"Lancet"},{"key":"1232_CR182","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1056\/NEJMoa2401802","volume":"393","author":"EW Hook","year":"2025","unstructured":"Hook, E. W. et al. One dose versus three doses of benzathine penicillin G in early syphilis. N. Engl. J. Med. 393, 869\u2013878 (2025).","journal-title":"N. Engl. J. Med."},{"key":"1232_CR183","doi-asserted-by":"publisher","first-page":"ofae631.075","DOI":"10.1093\/ofid\/ofae631.075","volume":"12","author":"K Keith","year":"2025","unstructured":"Keith, K. et al. 217. Preliminary results from a clinical trial comparing the efficacy of cefixime versus penicillin G for the treatment of early syphilis. Open Forum Infect. Dis. 12, ofae631.075 (2025).","journal-title":"Open Forum Infect. Dis."},{"key":"1232_CR184","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofae142","volume":"11","author":"GY Callado","year":"2024","unstructured":"Callado, G. Y. et al. Syphilis Treatment: systematic review and meta-analysis investigating nonpenicillin therapeutic strategies. Open Forum Infect. Dis. 11, ofae142 (2024).","journal-title":"Open Forum Infect. Dis."},{"key":"1232_CR185","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1056\/NEJMc2314441","volume":"390","author":"NAP Lieberman","year":"2024","unstructured":"Lieberman, N. A. P. et al. Near-universal resistance to macrolides of Treponema pallidum in North America. N. Engl. J. Med. 390, 2127\u20132128 (2024).","journal-title":"N. Engl. J. Med."},{"key":"1232_CR186","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/S1473-3099(23)00683-7","volume":"24","author":"M Ubals","year":"2024","unstructured":"Ubals, M. et al. Oral linezolid compared with benzathine penicillin G for treatment of early syphilis in adults (Trep-AB Study) in Spain: a prospective, open-label, non-inferiority, randomised controlled trial. Lancet Infect. Dis. 24, 404\u2013416 (2024).","journal-title":"Lancet Infect. Dis."},{"key":"1232_CR187","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.jadohealth.2023.11.014","volume":"74","author":"A de Vries","year":"2024","unstructured":"de Vries, A., den Daas, C., Willemstein, I. J. M., de Wit, J. B. F. P. & Heijne, J. C. M. Interventions promoting condom use among youth: a systematic review. J. Adolesc. Health 74, 644\u2013656 (2024).","journal-title":"J. Adolesc. Health"},{"key":"1232_CR188","doi-asserted-by":"publisher","first-page":"e141","DOI":"10.1016\/S2468-2667(22)00252-3","volume":"8","author":"L Johnson","year":"2023","unstructured":"Johnson, L. et al. Interventions to improve health and the determinants of health among sex workers in high-income countries: a systematic review. Lancet Public Health 8, e141\u2013e154 (2023).","journal-title":"Lancet Public Health"},{"key":"1232_CR189","doi-asserted-by":"publisher","first-page":"12668","DOI":"10.3390\/ijerph182312668","volume":"18","author":"TR Phillips","year":"2021","unstructured":"Phillips, T. R. et al. Oral, vaginal and anal sexual practices among heterosexual males and females attending a sexual health clinic: a cross-sectional survey in Melbourne, Australia. Int. J. Env. Res. Public Health 18, 12668 (2021).","journal-title":"Int. J. Env. Res. Public Health"},{"key":"1232_CR190","doi-asserted-by":"publisher","DOI":"10.2196\/45871","volume":"7","author":"JJ Lee","year":"2023","unstructured":"Lee, J. J. et al. A peer-based intervention to increase HIV and sexually transmitted infection testing among latinx immigrant sexual minority men in the US Pacific Northwest: pilot randomized controlled trial conducted during the COVID-19 pandemic. JMIR Form. Res. 7, e45871 (2023).","journal-title":"JMIR Form. Res."},{"key":"1232_CR191","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.1002245","volume":"10","author":"MCD Almeida","year":"2022","unstructured":"Almeida, M. C. D. et al. Syphilis response policies and their assessments: a scoping review. Front. Public Health 10, 1002245 (2022).","journal-title":"Front. Public Health"},{"key":"1232_CR192","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.70212","volume":"7","author":"S Borji-Navan","year":"2024","unstructured":"Borji-Navan, S., Maleki, N. & Keramat, A. Efficacy of digital health interventions used for adolescent\u2019s sexual health: an umbrella review. Health Sci. Rep. 7, e70212 (2024).","journal-title":"Health Sci. Rep."},{"key":"1232_CR193","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1071\/SH22068","volume":"19","author":"J Gibbs","year":"2022","unstructured":"Gibbs, J. et al. Measuring and evaluating sexual health in the era of digital health: challenges and opportunities. Sex. Health 19, 336\u2013345 (2022).","journal-title":"Sex. Health"},{"key":"1232_CR194","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.915399","volume":"9","author":"RM Farquharson","year":"2022","unstructured":"Farquharson, R. M. et al. Time to healthcare seeking following the onset of symptoms among men and women attending a sexual health clinic in Melbourne, Australia. Front. Med. 9, 915399 (2022).","journal-title":"Front. Med."},{"key":"1232_CR195","doi-asserted-by":"publisher","DOI":"10.1177\/21501319231159973","volume":"14","author":"S Sul","year":"2023","unstructured":"Sul, S., Ferreira, L., Maia, A. C., Coelho, A. & Costa, A. Sexually transmitted infections and health literacy: a community-based preventive program. J. Prim. Care Community Health 14, 21501319231159973 (2023).","journal-title":"J. Prim. Care Community Health"},{"key":"1232_CR196","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1093\/cid\/ciz802","volume":"71","author":"VJ Cornelisse","year":"2020","unstructured":"Cornelisse, V. J. et al. Getting to the Bottom of It: sexual positioning and stage of syphilis at diagnosis, and implications for syphilis screening. Clin. Infect. Dis. 71, 318\u2013322 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"1232_CR197","doi-asserted-by":"publisher","first-page":"e696","DOI":"10.1093\/infdis\/jiaf628","volume":"233","author":"J Tran","year":"2025","unstructured":"Tran, J. et al. Digital anorectal examination to self-detect primary syphilis: a prospective cohort study. J. Infect. Dis.\u00a0233,\u00a0e696\u2013e705\u00a0(2025).","journal-title":"J. Infect. Dis."},{"key":"1232_CR198","doi-asserted-by":"publisher","first-page":"e393","DOI":"10.1093\/infdis\/jiaf310","volume":"232","author":"H Lai","year":"2025","unstructured":"Lai, H. et al. Impact and cost-effectiveness of regular self-digital anorectal examination on syphilis among gay, bisexual, and other men who have sex with men: a mathematical modeling study. J. Infect. Dis. 232, e393\u2013e402 (2025).","journal-title":"J. Infect. Dis."},{"key":"1232_CR199","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/S1473-3099(24)00236-6","volume":"24","author":"JM Molina","year":"2024","unstructured":"Molina, J. M. et al. Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): a multicentre, open-label, randomised trial with a 2\u2008\u00d7\u20082 factorial design. Lancet Infect. Dis. 24, 1093\u20131104 (2024).","journal-title":"Lancet Infect. Dis."},{"key":"1232_CR200","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1136\/sextrans-2024-056208","volume":"101","author":"PR Sokoll","year":"2025","unstructured":"Sokoll, P. R. et al. Efficacy of postexposure prophylaxis with doxycycline (Doxy-PEP) in reducing sexually transmitted infections: a systematic review and meta-analysis. Sex. Transm. Infect. 101, 59\u201367 (2025).","journal-title":"Sex. Transm. Infect."},{"key":"1232_CR201","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-026-68561-7","volume":"17","author":"H Lai","year":"2026","unstructured":"Lai, H. et al. Impact and cost-effectiveness of doxycycline post-exposure prophylaxis in Australian men who have sex with men. Nat. Commun. 17, 1846 (2026).","journal-title":"Nat. Commun."},{"key":"1232_CR202","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7302a1","volume":"73","author":"LH Bachmann","year":"2024","unstructured":"Bachmann, L. H. et al. CDC Clinical Guidelines on the use of doxycycline postexposure prophylaxis for bacterial sexually transmitted infection prevention, United States, 2024. MMWR. Recomm. Rep. 73, 1\u20138 (2024).","journal-title":"MMWR. Recomm. Rep."},{"key":"1232_CR203","doi-asserted-by":"publisher","unstructured":"Saunders, J. et al. British Association for Sexual Health and HIV (BASHH) UK national guideline for the use of doxycycline post-exposure prophylaxis (DoxyPEP) for the prevention of syphilis, 2025. Int. J. STD AIDS https:\/\/doi.org\/10.1177\/09564624251352053 (2025).","DOI":"10.1177\/09564624251352053"},{"key":"1232_CR204","doi-asserted-by":"publisher","first-page":"381","DOI":"10.5694\/mja2.52258","volume":"220","author":"VJ Cornelisse","year":"2024","unstructured":"Cornelisse, V. J., Riley, B. & Medland, N. A. Australian consensus statement on doxycycline post-exposure prophylaxis (doxy-PEP) for the prevention of syphilis, Chlamydia and gonorrhoea among gay, bisexual and other men who have sex with men. Med. J. Aust. 220, 381\u2013386\u00a0(2024).","journal-title":"Med. J. Aust."},{"key":"1232_CR205","doi-asserted-by":"publisher","first-page":"2400707","DOI":"10.2807\/1560-7917.ES.2025.30.26.2400707","volume":"30","author":"B Teker","year":"2025","unstructured":"Teker, B. et al. Emergent informal use of doxycycline post- and pre-exposure prophylaxis among men who have sex with men and transgender and gender diverse people, the Netherlands, 2024. Euro Surveill. 30, 2400707 (2025).","journal-title":"Euro Surveill."},{"key":"1232_CR206","doi-asserted-by":"publisher","DOI":"10.5694\/mja2.70180","volume":"224","author":"PM Latt","year":"2026","unstructured":"Latt, P. M. et al. Awareness, usage and perceptions of doxycycline post-exposure prophylaxis (doxyPEP) for prevention of sexually transmitted infections in Australia: insights from a national cross-sectional survey. Med. J. Aust. 224, e70180 (2026).","journal-title":"Med. J. Aust."},{"key":"1232_CR207","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1093\/jac\/dkad129","volume":"78","author":"FYS Kong","year":"2023","unstructured":"Kong, F. Y. S., Kenyon, C. & Unemo, M. Important considerations regarding the widespread use of doxycycline chemoprophylaxis against sexually transmitted infections. J. Antimicrob. Chemother. 78, 1561\u20131568 (2023).","journal-title":"J. Antimicrob. Chemother."},{"key":"1232_CR208","doi-asserted-by":"publisher","DOI":"10.1177\/2515135520923887","volume":"8","author":"EDG McIntosh","year":"2020","unstructured":"McIntosh, E. D. G. Development of vaccines against the sexually transmitted infections gonorrhoea, syphilis, chlamydia, herpes simplex virus, human immunodeficiency virus and Zika virus. Ther. Adv. Vaccines Immunother. 8, 2515135520923887 (2020).","journal-title":"Ther. Adv. Vaccines Immunother."},{"key":"1232_CR209","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1016\/S0140-6736(17)31449-6","volume":"390","author":"H Petousis-Harris","year":"2017","unstructured":"Petousis-Harris, H. et al. Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study. Lancet 390, 1603\u20131610 (2017).","journal-title":"Lancet"},{"key":"1232_CR210","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/S1473-3099(21)00812-4","volume":"22","author":"WE Abara","year":"2022","unstructured":"Abara, W. E. et al. Effectiveness of a serogroup B outer membrane vesicle meningococcal vaccine against gonorrhoea: a retrospective observational study. Lancet Infect. Dis. 22, 1021\u20131029 (2022).","journal-title":"Lancet Infect. Dis."},{"key":"1232_CR211","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofae562","volume":"11","author":"AR Raccagni","year":"2024","unstructured":"Raccagni, A. R. et al. Breakthrough rectal Neisseria gonorrhoeae infections after meningococcal B vaccination: microbiological and clinical features. Open Forum Infect. Dis. 11, ofae562 (2024).","journal-title":"Open Forum Infect. Dis."},{"key":"1232_CR212","doi-asserted-by":"publisher","unstructured":"Seib, K. et al. Meningococcal B vaccine to prevent Neisseria gonorrhoeae infection. N. Engl. J. Med. https:\/\/doi.org\/10.1056\/nejmoa2516739 (2026).","DOI":"10.1056\/nejmoa2516739"},{"key":"1232_CR213","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(25)00543-2","volume":"25","author":"F Martin\u00f3n-Torres","year":"2025","unstructured":"Martin\u00f3n-Torres, F. & Dur\u00e1n-Parrondo, C. Galicia\u2019s gonorrhoea vaccination programme. Lancet Infect. Dis. 25, e625 (2025).","journal-title":"Lancet Infect. Dis."},{"key":"1232_CR214","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2025.106582","volume":"91","author":"SN Ladhani","year":"2025","unstructured":"Ladhani, S. N. et al. The United Kingdom meningococcal vaccine (4CMenB) programme against gonorrhoea: a review of the evidence and knowledge gaps. J. Infect. 91, 106582 (2025).","journal-title":"J. Infect."},{"key":"1232_CR215","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/infdis\/jiae123","volume":"231","author":"D Nikitin","year":"2025","unstructured":"Nikitin, D., Whittles, L. K., Imai-Eaton, J. W. & White, P. J. Cost-effectiveness of 4CMenB Vaccination Against Gonorrhea: importance of dosing schedule, Vaccine Sentiment, Targeting Strategy, and Duration of Protection. J. Infect. Dis. 231, 71\u201383 (2025).","journal-title":"J. Infect. Dis."},{"key":"1232_CR216","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004849","volume":"22","author":"SL Gottlieb","year":"2025","unstructured":"Gottlieb, S. L., Rees, H. & Peters, R. P. H. Vaccines to prevent bacterial sexually transmitted infections: promise, progress, and public health potential. PLoS Med. 22, e1004849 (2025).","journal-title":"PLoS Med."},{"key":"1232_CR217","doi-asserted-by":"publisher","first-page":"e467","DOI":"10.1016\/S2589-7500(21)00117-5","volume":"3","author":"SD Young","year":"2021","unstructured":"Young, S. D., Crowley, J. S. & Vermund, S. H. Artificial intelligence and sexual health in the USA. Lancet Digit. Health 3, e467\u2013e468 (2021).","journal-title":"Lancet Digit. Health"},{"key":"1232_CR218","doi-asserted-by":"publisher","DOI":"10.1177\/20552076251361749","volume":"11","author":"AJ King","year":"2025","unstructured":"King, A. J. et al. Sexual health service users\u2019 perspectives on artificial intelligence applications for identification of lesions associated with sexually transmissible infections: a qualitative study. Digit. Health 11, 20552076251361749 (2025).","journal-title":"Digit. Health"},{"key":"1232_CR219","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-024-03512-x","volume":"22","author":"NN Soe","year":"2024","unstructured":"Soe, N. N. et al. Evaluation of artificial intelligence-powered screening for sexually transmitted infections-related skin lesions using clinical images and metadata. BMC Med. 22, 296 (2024).","journal-title":"BMC Med."},{"key":"1232_CR220","doi-asserted-by":"publisher","unstructured":"Soe, N. N. et al. Diagnostic accuracy of commercial large language models for anogenital skin lesion images: a comparative study of Gemini, Claude and ChatGPT. J. Infect. Dis. https:\/\/doi.org\/10.1093\/infdis\/jiag258 (2026).","DOI":"10.1093\/infdis\/jiag258"},{"key":"1232_CR221","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12911-024-02426-1","volume":"24","author":"M Hu","year":"2024","unstructured":"Hu, M., Peng, H., Zhang, X., Wang, L. & Ren, J. Building gender-specific sexually transmitted infection risk prediction models using CatBoost algorithm and NHANES data. BMC Med. Inf. Decis. Mak. 24, 24 (2024).","journal-title":"BMC Med. Inf. Decis. Mak."},{"key":"1232_CR222","doi-asserted-by":"publisher","first-page":"ofae011","DOI":"10.1093\/ofid\/ofae011","volume":"11","author":"PM Latt","year":"2024","unstructured":"Latt, P. M. et al. Identifying individuals at high risk for HIV and sexually transmitted infections with an artificial intelligence-based risk assessment tool. Open Forum Infect. Dis. 11, ofae011 (2024).","journal-title":"Open Forum Infect. Dis."},{"key":"1232_CR223","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-025-22933-8","volume":"25","author":"PM Latt","year":"2025","unstructured":"Latt, P. M. et al. Evaluation of artificial intelligence (AI) chatbots for providing sexual health information: a consensus study using real-world clinical queries. BMC Public Health 25, 1788 (2025).","journal-title":"BMC Public Health"},{"key":"1232_CR224","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1136\/sextrans-2024-056217","volume":"100","author":"MCY Koh","year":"2024","unstructured":"Koh, M. C. Y., Ngiam, J. N., Tambyah, P. A. & Archuleta, S. ChatGPT as a tool to improve access to knowledge on sexually transmitted infections. Sex. Transm. Infect. 100, 528\u2013531\u00a0(2024).","journal-title":"Sex. Transm. Infect."},{"key":"1232_CR225","unstructured":"World Health Organization. Implementing the Global Health Sector Strategies on HIV, Viral Hepatitis and Sexually Transmitted Infections, 2022\u20132030: Report on Progress and Gaps 2024 (WHO, 2024)."},{"key":"1232_CR226","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1057\/s41599-023-02079-x","volume":"10","author":"Z Chen","year":"2023","unstructured":"Chen, Z. Ethics and discrimination in artificial intelligence-enabled recruitment practices. Humanit. Soc. Sci. Commun. 10, 567 (2023).","journal-title":"Humanit. Soc. Sci. Commun."},{"key":"1232_CR227","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2025.107922","volume":"157","author":"PM Latt","year":"2025","unstructured":"Latt, P. M. et al. Machine learning for personalized risk assessment of HIV, syphilis, gonorrhoea and Chlamydia: a systematic review and meta-analysis. Int. J. Infect. Dis. 157, 107922 (2025).","journal-title":"Int. J. Infect. Dis."},{"key":"1232_CR228","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.33512","volume":"8","author":"NN Soe","year":"2025","unstructured":"Soe, N. N. et al. Use of AI in identification of sexually transmitted infections and anogenital dermatoses: a systematic review and meta-analysis. JAMA Netw. Open 8, e2533512 (2025).","journal-title":"JAMA Netw. Open"},{"key":"1232_CR229","doi-asserted-by":"publisher","DOI":"10.1016\/j.landig.2025.100894","volume":"7","author":"M Liu","year":"2025","unstructured":"Liu, M. et al. Early detection of sexually transmitted infections from skin lesions with deep learning: a systematic review and meta-analysis. Lancet Digit. Health 7, 100894 (2025).","journal-title":"Lancet Digit. Health"},{"key":"1232_CR230","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1097\/OLQ.0000000000000022","volume":"40","author":"M Bissessor","year":"2013","unstructured":"Bissessor, M. et al. The etiology of infectious proctitis in men who have sex with men differs according to HIV status. Sex. Transm. Dis. 40, 768\u2013770 (2013).","journal-title":"Sex. Transm. Dis."},{"key":"1232_CR231","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab137","volume":"8","author":"EPF Chow","year":"2021","unstructured":"Chow, E. P. F. et al. Nonclassical pathogens as causative agents of proctitis in men who have sex with men. Open Forum Infect. Dis. 8, ofab137 (2021).","journal-title":"Open Forum Infect. Dis."},{"key":"1232_CR232","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.bpg.2009.04.010","volume":"23","author":"RJ Felt-Bersma","year":"2009","unstructured":"Felt-Bersma, R. J. & Bartelsman, J. F. Haemorrhoids, rectal prolapse, anal fissure, peri-anal fistulae and sexually transmitted diseases. Best. Pract. Res. Clin. Gastroenterol. 23, 575\u2013592 (2009).","journal-title":"Best. Pract. Res. Clin. Gastroenterol."},{"key":"1232_CR233","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1136\/pmj.2006.048488","volume":"82","author":"E Hamlyn","year":"2006","unstructured":"Hamlyn, E. & Taylor, C. Sexually transmitted proctitis. Postgrad. Med. J. 82, 733\u2013736 (2006).","journal-title":"Postgrad. Med. J."},{"key":"1232_CR234","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1001\/jama.2025.5009","volume":"333","author":"M Silverstein","year":"2025","unstructured":"Silverstein, M. et al. Screening for syphilis infection during pregnancy: US preventive services task force reaffirmation recommendation statement. J. Am. Med. Assoc. 333, 2006\u20132012 (2025).","journal-title":"J. Am. Med. Assoc."},{"key":"1232_CR235","unstructured":"National Advisory Committee on Sexually Transmitted and Blood-Borne Infections. Recommendations on screening for Chlamydia trachomatis and Neisseria gonorrhoeae for non-pregnant adults\/adolescents. Canada.ca https:\/\/go.nature.com\/4ywRk8G (2024)."},{"key":"1232_CR236","unstructured":"National Advisory Committee on Sexually Transmitted and Blood-Borne Infections. Syphilis screening recommendations for non-pregnant adults and adolescents. Canada.ca https:\/\/go.nature.com\/4fvzUAO (2024)."},{"key":"1232_CR237","unstructured":"Coleman, H. et al. BASHH Summary Guidance on Testing for Sexually Transmitted Infections, 2023 (BASHH, 2023)."},{"key":"1232_CR238","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1177\/09564624241280406","volume":"35","author":"M Kingston","year":"2024","unstructured":"Kingston, M. et al. BASHH UK guidelines for the management of syphilis 2024. Int. J. STD AIDS 35, 1142\u20131160 (2024).","journal-title":"Int. J. STD AIDS"},{"key":"1232_CR239","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/jdv.16946","volume":"35","author":"M Janier","year":"2021","unstructured":"Janier, M. et al. 2020 European guideline on the management of syphilis. J. Eur. Acad. Dermatol. Venereol. 35, 574\u2013588 (2021).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"1232_CR240","doi-asserted-by":"publisher","unstructured":"Unemo, M. et al. 2020 European guideline for the diagnosis and treatment of gonorrhoea in adults. Int. J. STD AIDS https:\/\/doi.org\/10.1177\/0956462420949126 (2020).","DOI":"10.1177\/0956462420949126"},{"key":"1232_CR241","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1177\/09564624251323678","volume":"36","author":"JA White","year":"2025","unstructured":"White, J. A. et al. 2025 European guideline on the management of Chlamydia trachomatis infections. Int. J. STD AIDS 36, 434\u2013449 (2025).","journal-title":"Int. J. STD AIDS"}],"container-title":["Nature Reviews Gastroenterology & Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41575-026-01232-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41575-026-01232-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41575-026-01232-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T13:01:25Z","timestamp":1793019685000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41575-026-01232-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":241,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["1232"],"URL":"https:\/\/doi.org\/10.1038\/s41575-026-01232-6","relation":{},"ISSN":["1759-5045","1759-5053"],"issn-type":[{"value":"1759-5045","type":"print"},{"value":"1759-5053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]},"assertion":[{"value":"3 July 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.M.K. has received research support from Hologic and Gilead Sciences. M.J.L. has received consultancy fees from Randox Health. E.P.F.C. has received research support from Gilead Sciences and Merck and has received consultancy fees from Roche and Merck. The\u00a0other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}